New report covers how to advance personalized medicine
HHS has released a 128-page report on realizing the promise of pharmacogenomics (PGx). The report discusses, among other issues, the educational needs of pharmacists, physicians, and other health professionals; PGx tests sold over the counter in drugstores; and the liability to M.D.s and R.Ph.s from off-label use of PGx.
HHS has released a 128-page report on realizing the promise of pharmacogenomics (PGx). The report discusses, among other issues, the educational needs of pharmacists, physicians, and other health professionals; PGx tests sold over the counter in drugstores; and the liability to M.D.s and R.Ph.s from off-label use of PGx. In addition, the document states that FDA will introduce a new format for drug labels that will include a PGx section in a prominent box. At present, there are more than 20 approved drugs whose labeling makes reference to PGx testing. HHS is seeking comments to the report by June 1. To access the draft, go to:
